Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.
about
Metabolomics and Its Application to Acute Lung DiseasesBlood transcriptomics and metabolomics for personalized medicineSystematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infectionsBiomarkers of progression of chronic obstructive pulmonary disease (COPD)Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine ModelCGDM: collaborative genomic data model for molecular profiling data using NoSQL.Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics.Application of proteomics and peptidomics to COPD.Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshopMultimarker screening of oxidative stress in aging.Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.Modules, networks and systems medicine for understanding disease and aiding diagnosis.Genetics of allergic diseases.Biomarkers in neonatology: the new "omics" of bronchopulmonary dysplasia.Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis.Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia.Metabolic alterations in the sera of Chinese patients with mild persistent asthma: a GC-MS-based metabolomics analysis.Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.Adaptation of a difficult-to-manage asthma programme for implementation in the Dutch context: a modified e-DelphiThe Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.Translational models of lung disease.Proteomics of pulmonary hypertension: could personalized profiles lead to personalized medicine?Asthma and COPD proteomics: current approaches and future directions.Proteomic profiling of eccrine sweat reveals its potential as a diagnostic biofluid for active tuberculosis.Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.The application of FAIMS gas analysis in medical diagnostics.Clinical implications of omics and systems medicine: focus on predictive and individualized treatment.Metabolomics biomarkers for tuberculosis diagnostics: current status and future objectives.Improving the diagnosis of eosinophilic asthma.Discovery of urine biomarkers for bladder cancer via global metabolomics.Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry.Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Systems Biology and Clinical Practice in Respiratory Medicine. The Twain Shall Meet.Promising but still uncertain steps towards better prediction of functional outcome in ICU patients.LSC 2016: from system approaches in lung disease to getting the job you want.The evolution of sputum cytometry to assess bronchitis.Queens beat one-eyed jacks, but nobody's played the ace yet. Adipokines as chronic obstructive pulmonary disease biomarkers.
P2860
Q26765930-E65D4EE1-A44F-4AC3-8A4D-613BDE88F765Q26772073-8E64807B-DE4C-466C-8B1C-139AE01B8AA0Q26782662-5848BE77-F3FF-4C09-A8B8-93516AE89309Q26996356-3E174B0A-356A-422A-B441-31269EC5EBB2Q27027259-56138898-7AF0-4974-B388-C2179ED2DC18Q28383918-5B0F4539-1C3B-49EE-B412-0683D0081152Q31121572-2B385A6E-ED78-4B01-B8D6-BFE88D2C8ADDQ33470198-EA3F9714-A8DF-48CA-9F7B-7881DB893B03Q33634488-94010B86-1A9F-44B4-AD0E-D722F406C943Q33658456-B5AFDA0D-F0D7-40E2-A651-2605FEE8F7FCQ33869631-438B30AB-AA72-4AF6-ABC1-F904F94E492FQ34014251-4CEB0C7A-BBB1-49CE-AC40-948B166DC2ABQ34274539-92F70492-B99E-4C36-89AA-8953CFE921C4Q34624769-BDAC8BA4-C2DC-4110-9CE9-9969B3D1D411Q35556785-9323BCEF-D315-4FDD-96AB-7CFCE5B70E5AQ35681161-EE558044-C3E2-4DAC-9E7B-5DA56BA8D5AAQ36055240-8A396201-7C20-4076-A5DE-C332E8AB9F79Q36166179-006365DE-56F5-43A5-BE88-DE1BC08F27C9Q36254528-65B4B0FE-7328-4F45-B148-C4D633D0AB36Q36907742-D4D7FA33-45CF-42EE-8030-AD7DF244A592Q37634950-532FB0DB-0020-4100-BD93-9D7FE9794CA1Q37679914-CCFBDE1F-AFC4-4964-9AE1-120608AF0278Q38261287-5E0FAC76-DA20-4BE6-A4E7-E9DF0839BAC5Q38269463-56AD063E-14A9-44AF-8C5D-397DA9F2B332Q38287694-C997D341-19DA-4C01-9009-9DC7284990EBQ38395129-D7517976-4544-4C4A-86CA-0B917F99EB4EQ38528048-19B79266-A7F8-4DDF-971B-D0CA7C8C4C8CQ38553136-81F61351-F572-4211-B065-70BD27190CBFQ38739645-F03CBF1B-DE77-419E-8F34-56B302E2F24DQ38769147-F135B43B-4D63-43FD-BF8B-664BA96C36A3Q38821540-0EB316D0-3C62-4A3E-8801-ECF8395FAE52Q38822316-5E17DA29-E224-4819-A133-7EFFC830B844Q38853602-93F734A0-4B25-4C10-9495-426FD4484D5FQ38856893-0E16FC83-4377-4CAC-86EA-AB821D1486F9Q39402027-EBB88B34-0039-4A78-9F31-1D8C241A4A45Q39458757-82D016D2-CCCC-4A5B-A32A-950339179277Q41114407-16C6AA33-4013-4EA3-BEB8-E81A9EE1F382Q42431458-AFFFD6C1-1F8E-4BF2-9A52-00E967712190Q42562158-4182F015-0819-4592-975A-D5A80AFAD655Q43197596-2836DA62-0692-4F5F-A031-6D36A28EAADD
P2860
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.
@en
type
label
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.
@en
prefLabel
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.
@en
P2093
P50
P1476
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases.
@en
P2093
Amphun Chaiboonchoe
Arnaldo D'Amico
Ben Nicholas
Christos Rossios
Craig E Wheelock
David Balgoma
Dominic Burg
Hassan Ahmed
Joost Brandsma
Paul J Skipp
P304
P356
10.1183/09031936.00078812
P50
P577
2013-02-08T00:00:00Z